Venture Life Group Plc
VLG:LN
Latest Coverage
Overview
Company Profile
We are committed to providing innovative and efficacious products for the self-care market for people who want live a healthier life. Our vision is become a key trusted global leader in self-care products through our knowledge, expertise and capability.
Classification
Sector Healthcare
Industry Pharmaceuticals
Subindustry Pharmaceutical Manufacturers - Specialty & Generic
Financials
News & Media
Latest Coverage
Corporate
Board of Directors
Paul McGreevy
Non-Executive Chair
Paul joined Venture Life as Non-Exec Chair in May 2022. Paul currently holds several Non-Exec roles in healthcare, retail, and manufacturing. Over the past 30+ years Paul has held numerous Senior Executive position across FMCG and retail, enabling a broad perspective across the business. Having had a successful strategic consulting career across diverse sectors, an advisor to various PE, and extended experience of M&A, Paul brings a wealth of experience to the board. Paul chairs the Group’s Nomination Committee and is a member of the Audit and Risk and Remuneration Committees.
Jerry Randall
Chief Executive Officer
Jerry co-founded Venture Life in 2010. From 2000 to 2009, Jerry was CFO and co-founder of Sinclair Pharma plc, an AIM listed international specialty pharma business, now listed on the AIM market in London. Sinclair was founded in August 2000 when Jerry completed the management buy-in. Jerry was also on the Board of Silence Therapeutics plc, an AIM listed biotech development business, from 2008 to 2013. Initially a Non-Executive Director, Jerry became a Non-Executive Chairman in 2010 and moved to Executive Chairman in 2012. Jerry enjoyed a career initially in corporate finance and was involved in buy-ins and acted as adviser to both private and quoted companies between 1993 and 2000, in capacities as nominated adviser and in practice with KPMG. Jerry has been involved in a number of flotations and transactions on the Official List, Unlisted Securities Market and AIM, as well as raising private equity. He qualified as a chartered accountant with KPMG in 1990.
Gianluca Braguti
Chief Manufacturing Officer
Gianluca joined the Board in March 2014 following the acquisition by Venture Life of Biokosmes, the company he founded. Gianluca began his career working in his father’s pharmacy and then, after he graduated as a pharmacist, continued working for several years in the Milano University cosmetic Research and Development department researching cosmetic applications for raw materials used in different fields. In 1990 he started developing formulations for Italian cosmetic brands mainly in the perfumery and pharmacy area and started his experience in contract manufacturing business, Biokosmes. In 1999 Biokosmes started developing and manufacturing medical devices, selling predominantly in Europe. In 2002 Biokosmes passed its first FDA inspection, and started exporting its products to the US.
Daniel Wells
Chief Financial Officer
Daniel joined the team following the acquisition of private equity backed BBI Healthcare where he had been Finance Director for two years and was subsequently appointed as Chief Financial Officer of Venture Life Group in December 2021. Prior to this, he enjoyed a career at Mitie Group PLC having spent ten years in a variety of senior finance and commercial roles across the UK and Ireland, including as Account Director for a major retail customer with revenues of over £50m per annum. Daniel began his career in the private healthcare sector as part of the Corporate Finance team at Hazlewoods LLP. He qualified as an Accountant in 2011 (ICAEW) and is also a member of the AAT.
Mark Adams
Non-Executive Director and Chair of Audit Committee
Mark joined Venture Life in October 2022, bringing a wealth of relevant experience and expertise to the Board, including significant time as a main Board director of publicly listed companies. His most recent role was as Group Finance Director at Marlowe plc, a UK leader in business critical services and software which assure safety and regulatory compliance. Prior to Marlowe, Mark has held senior financial and board level roles at Stobart Group, Pets at Home Group plc, easyJet plc and a number of other businesses. Mark is currently a Non-Executive Director and Audit Committee Chair at One Media iP Group plc and Development Media International CIC.
Carl Dempsey
Non-Executive Director
Carl Dempsey joined the Venture Life board as Non-Executive Director in September 2018. Until recently, Carl was Worldwide Vice President Global Customer Management at Johnson & Johnson ("J&J") where he was responsible for global sales of US$3.6 billion across 22 countries. During his 29 year career at J&J, Carl had particular responsibility for developing the Health and Wellness Partnership strategy. He also led the successful integration of Pfizer Consumer Healthcare across Europe, Africa and the Middle East which included the Listerine mouthwash brand.